News

Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings. 

artificial intelligence in healthcare

Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments. 

FDA recall medical device recall product recall

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

Thumbnail

Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease. 

Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]

All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

heart drugs with stethoscope

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?

passport visa foreign international travel

ACR and other medical societies recently wrote to the secretaries of State and Homeland Security to voice their concern about ongoing staffing issues. 

Lung cancer screening stethoscope

Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings. 

Thumbnail

The U.S. Department of Justice is appealing a lower court’s ruling that would see 16,000 federal employees return to work, including many from Veterans Affairs. 

Alnylam Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for vutrisiran, a subcutaneous injection the company sells under the brand name Amvuttra, to treat adult patients with transthyretin amyloid cardiomyopathy (ATTR-CM).

The subcutaneous drug, sold under the brand name Amvuttra, joins an ATTR-CM market that already includes Pfizer’s tafamidis (Vyndaqel, Vyndamax) and BridgeBio’s acoramidis (Attruby).

lung cancer pulmonary nodule chest

By the time the patient was diagnosed with advanced stage lung cancer, his tumor was double the size it was when it first appeared on imaging in 2017. 

progress step forward business announce

Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

Around the web

Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings. 

Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments. 

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.